MACROGENICS INC 8-K

What Happened
Macrogenics, Inc. (NASDAQ: MGNX) filed a Form 8-K on May 13, 2026 to announce its financial and operating results for the quarter ended March 31, 2026. The company attached a press release with those results as Exhibit 99.1 to the 8-K. The filing clarifies that the information and exhibit are furnished (not “filed”) for purposes of Section 18 of the Exchange Act and are not incorporated by reference in other filings except where specifically referenced.

Key Details

• Filing date: May 13, 2026; quarter covered: March 31, 2026.
• Press release containing the results is attached as Exhibit 99.1 to the Form 8-K.
• The filing includes Inline XBRL interactive data (Exhibit 104).
• Report signed by Jeffrey Peters, Senior Vice President, General Counsel and Corporate Secretary.

Why It Matters
This 8-K notifies investors that Macrogenics has released its latest quarterly results (earnings, revenue and other operating metrics) and directs market participants to the press release for the details needed to assess near-term performance. Because the material is furnished rather than filed, it is not subject to the Exchange Act’s Section 18 liability and won’t be automatically incorporated into future SEC filings unless expressly referenced. Investors should review Exhibit 99.1 (the press release) for the specific financial figures and any management commentary on results or outlook.